Brown Trout Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Brown Trout Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Brown Trout Management from 13F filings

Historical chart of Brown Trout Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Brown Trout Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Brown Trout Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.0M 3.2k 945.68

More positions owned by Brown Trout Management

Nuvalent Inc-a (NUVL)
Apogee Therapeutics (APGE)
Chart Industries (GTLS)
Bandwidth Note 0.500% 4/0 (Principal)
Taylor Morrison Hom (TMHC)
Sabre Glbl Note 7.320% 8/0 (Principal)
Rapid7 Note 0.250% 3/1 (Principal)
Mgp Ingredients Note 1.875%11/1 (Principal)
Veritone Note 1.750%11/1 (Principal)
Amphastar Pharmaceuticals In Note 2.000% 3/1 (Principal)
The Realreal Note 1.000% 3/0 (Principal)
Five9 Note 1.000% 3/1 (Principal)
Shake Shack Note 3/0 (Principal)
Etsy Note 0.250% 6/1 (Principal)
Hewlett Packard Enterprise C 7.625 Mand Conv (HPE.PC)

View all positions for Brown Trout Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Highbridge Capital Management
DeepCurrents Investment Group
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Oaktree Capital Management
Bnp Paribas Investment Partners
Russell Investments
FMR
Financial Consulate
Advent Capital Management
Jpmorgan Chase & Co
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1